Semaglutide in type 2 diabetes with chronic kidney disease at high risk progression—real-world clinical practice

por Aviles Bueno, Beatriz, Soler, Maria Jose, Perez-Belmonte, Luis, Jimenez Millan, Anabel, Rivas Ruiz, Francisco, Garcia de Lucas, Maria Dolores
Publicado 2022

Real-world use of once-weekly semaglutide in patients with type 2 diabetes at an outpatient clinic in Spain

por Garcia de Lucas, Maria Dolores, Miramontes-González, Jose Pablo, Avilés-Bueno, Beatriz, Jiménez-Millán, Ana Isabel, Rivas-Ruiz, Francisco, Pérez-Belmonte, Luis M.
Publicado 2022

Agreement Between (18)F-FDG PET/CT and Whole-Body Magnetic Resonance Compared With Skeletal Survey for Initial Staging and Response at End-of-Treatment Evaluation of Patients With...

por Gómez León, Nieves, Aguado Bueno, Beatriz, Herreros Pérez, María, León Ramírez, Luisa F., Alegre, Adrián, Colletti, Patrick M., Rubello, Domenico, Carreras, José L., Delgado Bolton, Roberto C.
Publicado 2021

Efficacy and Safety of Semaglutide for the Management of Obese Patients With Type 2 Diabetes and Chronic Heart Failure in Real-World Clinical Practice

por Pérez-Belmonte, Luis M., Sanz-Cánovas, Jaime, García de Lucas, María D., Ricci, Michele, Avilés-Bueno, Beatriz, Cobos-Palacios, Lidia, Pérez-Velasco, Miguel A., López-Sampalo, Almudena, Bernal-López, M. Rosa, Jansen-Chaparro, Sergio, Miramontes-González, José P., Gómez-Huelgas, Ricardo
Publicado 2022